Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Catheter Cardiovasc Interv. 2020 Aug 3;97(7):1354–1366. doi: 10.1002/ccd.29098

TABLE 1.

Baseline characteristics of the study population stratified by tertiles of CardShock risk score and access site

CardShock tertile 1 (n = 55) CardShock tertile 2 (n = 54) CardShock tertile 3 (n = 44)
Parameter Radial (n = 41) Femoral (n = 14) Radial (n = 31) Femoral (n = 23) Radial (n = 10) Femoral (n = 34)
Demographics
 Age, years 66 (60, 70) 64.5 (52, 68)NS 63 (57, 72) 66 (60,72)NS 63.5 (52, 74) 69 (63, 75)NS
 Male 34 (82.9) 10 (71.4)NS 21 (67.7) 17 (73.9)NS 7 (70.0) 21 (61.8)NS
 BMI median (Q1, Q3) 28.4 (24.6, 32.3) 23.4 (21.8, 27)* 28.9 (25.7, 33) 28.2 (23, 30.2)NS 32.9 (31.3, 35.1) 28.1 (24.5, 33.1)NS
 Cerebrovascular disease 0 (0.0) 1 (7.1)NS 1 (3.2) 5 (21.7)* 4 (40.0) 13 (38.2)NS
Clinical characteristics
 Diabetes mellitus 16 (39.0) 4 (28.6)NS 13 (41.9) 10 (43.4)NS 6 (60.0) 23 (67.7)NS
 Index GFR < 60 ml/min 17 (41.5) 5 (35.7)NS 17 (54.8) 17 (73.9)NS 6 (60.0) 26 (76.5)NS
 Prior MI/PCI/valve surgery 6 (14.6) 3 (21.4)NS 5 (16.1) 7 (30.4)NS 2 (20.0) 6 (17.6)NS
 EF ≤ 30% 20 (48.8) 9 (64.3)NS 18(58.1) 17 (73.9)NS 5 (50.0) 24 (70.6)NS
 Mechanical ventilation 14 (34.1) 9 (64.3)* 18 (58.0) 20 (87.0)* 10 (100) 34 (100)NS
 Number of vasopressors 1 (0, 1) 1 (1, 2)NS 1 (1, 2) 2 (1, 3)** 3 (2, 3) 3 (3, 3)NS
 Systolic BP 90 (87, 95) 93.5 (82, 100)NS 90 (80, 100) 75 (70, 95)** 75 (70, 82) 70 (60, 75)*
 Cardiac arrest 6 (14.6) 5 (35.7)NS 10 (32.2) 10 (43.5)NS 3 (30.0) 17 (50.0)NS
 Smoking history 26 (63.4) 7 (50.0)NS 15 (48.4) 12 (52.2)NS 6 (60.0) 6 (17.6)NS
Severity of shock and hemodynamics
 CardShock score 3 (2,3) 3 (2, 3)NS 5 (4, 5) 5 (4,6)NS 6 (6, 7) 7 (6, 7)NS
 RA 12 (10, 19) 12 (10, 16)NS 13 (11, 15) 15 (10, 20)NS 16 (14, 17) 15 (11,18)NS
 PCWP 20 (16, 26.5) 20 (19, 30)NS 23 (18, 31)NS 24 (16, 30)NS 22 (21, 30) 24 (15, 27)NS
 RA/wedge ratio 0.6 (0.6, 0.7) 0.6 (0.4, 0.7)NS 0.6 (0.4, 0.7) 0.6 (0.5, 0.8)NS 0.6 (0.55, 0.6) 0.6 (0.5, 0.8)NS
 Baseline lactate 2 (1.3, 2.8) 2.1 (1.5, 3.5)NS 2.75 (1.9, 6.4) 3.2 (2.1, 6.4)NS 3.8 (1.7, 5.1) 3.9 (2.2, 7.4)NS
 Baseline CPO 0.8 (0.6, 0.9) 0.7 (0.4, 0.8)NS 0.7 (0.6, 0.9) 0.9 (0.6, 1.0)NS 0.8 (0.7, 0.8) 0.6 (0.5, 0.7)NS
 Baseline PAPi 1.4 (0.9, 2.4) 1.1 (0.7, 1.7)NS 1.4 (1.0, 2.0) 1.2 (0.8, 1.8)NS 1.2 (0.9, 1.6) 1.8 (0.8, 2.1)NS
 SCAI shock
  C 41 (100) 14 (100)NS 27 (87.1) 13 (56.5)** 0 (0.0) 0 (0.0)NS
  D 0 (0.0) 0 (0.0) 4 (12.9) 10 (43.5) 5 (50.0) 21 (61.8)
  E 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 5 (50.0) 13 (38.2)
Clinical presentation
 NSTEMI 20 (48.8) 5 (35.7)NS 13 (41.9) 12 (52.2)NS 5 (50.0) 16 (47.1)NS
 STEMI 20 (48.8) 9 (64.3) 17 (54.8) 11 (47.8) 5 (50.0) 18 (52.9)
 Unstable angina 1 (2.4) 0 (0.0)NS 1 (3.2) 0 (0.0)NS 0 (0.0) 0 (0.0)NS

Note: Values presented are median (Q1, Q3) or frequency (percent), where appropriate.

Abbreviations: CABG, coronary artery bypass grafting; CAD, coronary artery disease; CPO, cardiac power output; EF, ejection fraction; NS, nonsignificant; NSTEMI, non-ST segment elevation myocardial infarction; PAPi, pulmonary arterial pulsatility index; PCI, percutaneous coronary intervention; PCWP, pulmonary capillary wedge pressure; RA, right atrium; SCAI, Society for Cardiovascular Angiography and Interventions; STEMI, ST-elevation myocardial infarction.

*

p < .05.

**

p < .01.